Minimally invasive biomarker confirms glial activation present in Alzheimer&#39;s disease: a preliminary study

QR Code

Minimally invasive biomarker confirms glial activation present in Alzheimer&#39;s disease: a preliminary study

Napapon Sailasuta, Kent Harris, Thao Tran, Brian RossClinical MR Unit, Huntington Medical Research Institutes, Pasadena, CA, USAAbstract: We applied 13C magnetic resonance spectroscopy (MRS), a nonradioactive, noninvasive brain imaging technique, to quantify the oxidation of [1-13C] acetate in a con...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Tran T, Harris K, Sailasuta N, Ross B
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2011
Sujets:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Accès en ligne:	https://doaj.org/article/5ba6dcdf4ac942c3afd7e47b352ab4ae
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Cost-effectiveness analysis of memantine for moderate-to-severe Alzheimer&#39;s disease in the Netherlands
par: Hoogveldt B, et autres
Publié: (2011)

Alzheimer's disease and blood-based biomarkers – potential contexts of use
par: Zvěřová M
Publié: (2018)

Editor&#39;s choice
par: Pinder RM
Publié: (2012)

Present and prospective clinical therapeutic regimens for Alzheimer&rsquo;s disease
par: Mustafa M Husain, et autres
Publié: (2008)

Galantamine treatment in Alzheimer&#39;s disease: response and long-term outcome in a routine clinical setting
par: Wallin &Aring;K, et autres
Publié: (2011)

Corrigendum
par: Sailasuta N, et autres
Publié: (2011)

Decreased white matter integrity before the onset of delusions in patients with Alzheimer&#39;s disease: diffusion tensor imaging
par: Nakaaki S, et autres
Publié: (2012)

Rivastigmine in the treatment of Alzheimer's disease: an update
par: Maria Luisa Onor, et autres
Publié: (2007)

Review: management of Parkinson&#39;s disease
par: Pedrosa DJ, et autres
Publié: (2013)

The subjective perception of past, present, and future time in patients with Alzheimer's disease: a qualitative study
par: Shiromaru-Sugimoto A, et autres
Publié: (2018)

The genetics of Alzheimer's disease
par: Bagyinszky E, et autres
Publié: (2014)

Electroencephalography-driven approach to prodromal Alzheimer's disease diagnosis: from biomarker integration to network-level comprehension
par: Moretti DV
Publié: (2016)

Two cases of Alzheimer&#39;s disease showing deterioration of behavioral and psychological symptoms of dementia induced by switching from rivastigmine to donepezil
par: Kimura T, et autres
Publié: (2012)

Rehabilitating a brain with Alzheimer's: a proposal
par: Gonzalo Emiliano Aranda-Abreu, et autres
Publié: (2011)

Adjunctive therapy in Parkinson&#39;s disease: the role of rasagiline
par: Gaines KD, et autres
Publié: (2012)

Alzheimer&#39;s disease and primary open-angle glaucoma: is there a connection
par: Tsolaki F, et autres
Publié: (2011)

An update on the toxicity of A&beta; in Alzheimer&rsquo;s disease
par: J&uuml;rgen G&ouml;tz, et autres
Publié: (2008)

Long noncoding RNAs and Alzheimer's disease
par: Luo Q, et autres
Publié: (2016)

Alzheimer's disease and its treatment costs: case study in the Czech Republic
par: Mohelska H, et autres
Publié: (2015)

Do neurologists in Germany adhere to the national Parkinson&#39;s disease guideline?
par: Sabrina Schr&ouml;der, et autres
Publié: (2011)

Language impairment in Alzheimer's disease and benefits of acetylcholinesterase inhibitors
par: Ferris SH, et autres
Publié: (2013)

Domperidone effective in preventing rivastigmine-related gastrointestinal disturbances in patients with Alzheimer's disease
par: Kano O, et autres
Publié: (2013)

Retrospective case studies of the efficacy of caprylic triglyceride in mild-to-moderate Alzheimer's disease
par: Maynard SD, et autres
Publié: (2013)

Sleep disturbances in Parkinson&#39;s disease patients and management options
par: Claassen DO, et autres
Publié: (2011)

Brain amyloid &beta; protein and memory disruption in Alzheimer&rsquo;s disease
par: Weiming Xia
Publié: (2010)

Update on the use of memantine in Alzheimer&rsquo;s disease
par: Robert J van Marum
Publié: (2009)

Retrospective cohort study of the efficacy of caprylic triglyceride in patients with mild-to-moderate Alzheimer's disease
par: Maynard SD, et autres
Publié: (2013)

Biomarkers of neurodegeneration and glial activation validated in Alzheimer's disease assessed in longitudinal cerebrospinal fluid samples of Parkinson's disease.
par: Michael Bartl, et autres
Publié: (2021)

Genes associated with Alzheimer's disease: an overview and current status
par: Giri M, et autres
Publié: (2016)

Potential therapeutic effect of nanobased formulation of rivastigmine on rat model of Alzheimer&#39;s disease
par: Ismail MF, et autres
Publié: (2013)

The effects of memantine on behavioral disturbances in patients with Alzheimer's disease: a meta-analysis
par: Kishi T, et autres
Publié: (2017)

Minimally invasive surgery to the aortic arch – endovascular repair combined with debranching: 4 case reports
par: D.G. Harris, et autres
Publié: (2017)

Alzheimer's disease: Newer biomarkers
par: Ankit Dangi, et autres
Publié: (2021)

Electrophysiological Biomarkers of Epileptogenicity in Alzheimer’s Disease
par: Tingting Yu, et autres
Publié: (2021)

Ceruloplasmin and iron in Alzheimer&rsquo;s disease and Parkinson&rsquo;s disease: a synopsis of recent studies
par: Kristinsson J, et autres
Publié: (2012)

Clinical management of sleep disturbances in Alzheimer's disease: current and emerging strategies
par: Urrestarazu E, et autres
Publié: (2016)

Intrathecal corticosteroids might slow Alzheimer&rsquo;s disease progression
par: Joseph Martin Alisky
Publié: (2008)

Prediction of population with Alzheimer's disease in the European Union using a system dynamics model
par: Tomaskova H, et autres
Publié: (2016)

Brain ischemia and ischemic blood&ndash;brain barrier as etiological factors in sporadic Alzheimer&rsquo;s disease
par: Ryszard Pluta, et autres
Publié: (2008)

Cognitive dysfunction in major depression and Alzheimer's disease is associated with hippocampus–prefrontal cortex dysconnectivity
par: Sampath D, et autres
Publié: (2017)